Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Pacira BioSciences Inc shares valued at $266,405 were purchased by Cross Shawn on Nov 10 ’25. At $22.09 per share, Cross Shawn acquired 12,060 shares.
Also, Ceesay Abraham sold 2,354 shares, netting a total of over 64,005 in proceeds. Following the sale of shares at $27.19 each, the insider now holds 9,039 shares.
Before that, Ceesay Abraham had added 2,354 shares to its account. In a trade valued at $64,005, the Director bought Pacira BioSciences Inc shares for $27.19 each.
As published in a research note from Truist on July 25, 2025, Pacira BioSciences Inc [PCRX] has been rated up from a Hold to a Buy and the price target has been revised to $30. Analysts at Truist upgraded the stock from ‘”a Sell”‘ to ‘”a Hold”‘ outlook in a report released in late January. As of August 13, 2024, Truist has decreased its “Buy” rating to a “Sell” for PCRX. Earlier on August 12, 2024, RBC Capital Mkts downgraded its rating. Their new recommendation was “a Sector perform” for PCRX stock which previously was a “an Outperform”.
Analyzing PCRX Stock Performance
On last trading session, Pacira BioSciences Inc [NASDAQ: PCRX] plunged -1.08% to $23.86. The stock’s lowest price that day was $23.845, but it reached a high of $24.3 in the same session. During the last five days, there has been a surge of approximately 9.20%. Over the course of the year, Pacira BioSciences Inc shares have jumped approximately 38.40%. Shares of the company reached a 52-week high of $27.64 on 09/03/25 and a 52-week low of $18.17 on 01/06/25.
Support And Resistance Levels for Pacira BioSciences Inc (PCRX)
According to the 24-hour chart, there is a support level at 23.70, which, if violated, would cause prices to drop to 23.55. In the upper region, resistance lies at 24.16. The next price resistance is at 24.46. RSI (Relative Strength Index) is 58.12 on the 14-day chart, showing neutral technical sentiment.
Is Pacira BioSciences Inc subject to short interest?
Stocks of Pacira BioSciences Inc saw a sharp rise in short interest on 2025-10-31 jumping by 1.0 million shares to 7.28 million. Data from Yahoo Finance shows that the short interest on 2025-09-30 was 6.28 million shares. A jump of 13.7% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 13.98 of the overall float, the days-to-cover ratio (short ratio) jumped to 13.98.
Which companies own the most shares of Pacira BioSciences Inc (PCRX)?
In terms of Pacira BioSciences Inc share price expectations, FactSet research, analysts set an average price target of 25 in the next 12 months, up nearly 3.65% from the previous closing price of $24.12. Analysts anticipate Pacira BioSciences Inc stock to reach 63 by 2025, with the lowest price target being 12. In spite of this, 6 analysts ranked Pacira BioSciences Inc stock as Buy at the end of 2025.
